Vimarsana
Biggest News Aggregation in the World

Page 3 - Hookipa Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hookipa Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hookipa Pharma Today - Breaking & Trending Today

Rx Rundown: Vertex Pharmaceuticals, Vaxcyte, Cardinal Health and more - Vimarsana News

Rx Rundown: Vertex Pharmaceuticals, Vaxcyte, Cardinal Health and more

Check out this week’s medical marketing news, people on the move and industry chatter.

Off the Hookipa: Roche terminates $1B deal - Vimarsana News

Off the Hookipa: Roche terminates $1B deal

Hookipa Pharma Inc.’s nearly $1 billion collaboration with Roche Holding AG dissolved along with 30% of the company’s staff. The New York-based company said Roche ended the October 2022 deal involving the HB-700 program in treating KRAS mutated cancers but did not say why the agreement fell apart.

HOOKIPA Pharma Provides Update on Business Priorities and - Vimarsana News

HOOKIPA Pharma Provides Update on Business Priorities and

HOOKIPA to prioritize clinical development of HB-200 for the treatment of HPV16+ head and neck cancers and Gilead-partnered programs in infectious...

Hookipa Pharma (NASDAQ:HOOK) Trading Down 16.5% - Vimarsana News

Hookipa Pharma (NASDAQ:HOOK) Trading Down 16.5%

Shares of Hookipa Pharma Inc (NASDAQ:HOOK – Get Free Report) were down 16.5% during mid-day trading on Monday . The stock traded as low as $0.71 and last traded at $0.72. Approximately 9,262,100 shares were traded during trading, an increase of 749% from the average daily volume of 1,090,797 shares. The stock had previously closed […]

HOOKIPA Pharma Shares Soar After Gilead Sciences Investment - Vimarsana News

HOOKIPA Pharma Shares Soar After Gilead Sciences Investment

By Dean Seal Shares of HOOKIPA Pharma surged after the company said Gilead Sciences bought 15 million of its shares at about $1.42 apiece. The stock was up...